Literature DB >> 28620721

A novel gain-of-function mutation in the ITPR1 suppressor domain causes spinocerebellar ataxia with altered Ca2+ signal patterns.

Jillian P Casey1,2, Taisei Hirouchi3,4, Chihiro Hisatsune3, Bryan Lynch5, Raymond Murphy6, Aimee M Dunne7, Akitoshi Miyamoto3, Sean Ennis7, Nick van der Spek8, Bronagh O'Hici9, Katsuhiko Mikoshiba3, Sally Ann Lynch10,7.   

Abstract

We report three affected members, a mother and her two children, of a non-consanguineous Irish family who presented with a suspected autosomal dominant spinocerebellar ataxia characterized by early motor delay, poor coordination, gait ataxia, and dysarthria. Whole exome sequencing identified a novel missense variant (c.106C>T; p.[Arg36Cys]) in the suppressor domain of type 1 inositol 1,4,5-trisphosphate receptor gene (ITPR1) as the cause of the disorder, resulting in a molecular diagnosis of spinocerebellar ataxia type 29. In the absence of grandparental DNA, microsatellite genotyping of healthy family members was used to confirm the de novo status of the ITPR1 variant in the affected mother, which supported pathogenicity. The Arg36Cys variant exhibited a significantly higher IP3-binding affinity than wild-type (WT) ITPR1 and drastically changed the property of the intracellular Ca2+ signal from a transient to a sigmoidal pattern, supporting a gain-of-function disease mechanism. To date, ITPR1 mutation has been associated with a loss-of-function effect, likely due to reduced Ca2+ release. This is the first gain-of-function mechanism to be associated with ITPR1-related SCA29, providing novel insights into how enhanced Ca2+ release can also contribute to the pathogenesis of this neurological disorder.

Entities:  

Keywords:  Calcium signaling; Gain-of-function; ITPR1; Inositol 1,4,5-trisphosphate receptor 1; Non-progressive spinocerebellar ataxia; Spinocerebellar ataxia 29; Whole exome sequencing

Mesh:

Substances:

Year:  2017        PMID: 28620721     DOI: 10.1007/s00415-017-8545-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  39 in total

1.  Prevalence of inositol 1, 4, 5-triphosphate receptor type 1 gene deletion, the mutation for spinocerebellar ataxia type 15, in Japan screened by gene dosage.

Authors:  Masato Obayashi; Kinya Ishikawa; Yuishin Izumi; Makoto Takahashi; Yusuke Niimi; Nozomu Sato; Osamu Onodera; Ryuji Kaji; Masatoyo Nishizawa; Hidehiro Mizusawa
Journal:  J Hum Genet       Date:  2012-02-09       Impact factor: 3.172

2.  Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors.

Authors:  J C Tu; B Xiao; J P Yuan; A A Lanahan; K Leoffert; M Li; D J Linden; P F Worley
Journal:  Neuron       Date:  1998-10       Impact factor: 17.173

3.  Recessive and Dominant De Novo ITPR1 Mutations Cause Gillespie Syndrome.

Authors:  Sylvie Gerber; Kamil J Alzayady; Lydie Burglen; Dominique Brémond-Gignac; Valentina Marchesin; Olivier Roche; Marlène Rio; Benoit Funalot; Raphaël Calmon; Alexandra Durr; Vera Lucia Gil-da-Silva-Lopes; Maria Fernanda Ribeiro Bittar; Christophe Orssaud; Bénédicte Héron; Edward Ayoub; Patrick Berquin; Nadia Bahi-Buisson; Christine Bole; Cécile Masson; Arnold Munnich; Matias Simons; Marion Delous; Helene Dollfus; Nathalie Boddaert; Stanislas Lyonnet; Josseline Kaplan; Patrick Calvas; David I Yule; Jean-Michel Rozet; Lucas Fares Taie
Journal:  Am J Hum Genet       Date:  2016-04-21       Impact factor: 11.025

4.  Chronic suppression of inositol 1,4,5-triphosphate receptor-mediated calcium signaling in cerebellar purkinje cells alleviates pathological phenotype in spinocerebellar ataxia 2 mice.

Authors:  Adebimpe W Kasumu; Xia Liang; Polina Egorova; Daria Vorontsova; Ilya Bezprozvanny
Journal:  J Neurosci       Date:  2012-09-12       Impact factor: 6.167

5.  Non-progressive congenital ataxia with or without cerebellar hypoplasia: a review of 34 subjects.

Authors:  M Steinlin; B Zangger; E Boltshauser
Journal:  Dev Med Child Neurol       Date:  1998-03       Impact factor: 5.449

6.  Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia.

Authors:  Brent L Fogel; Hane Lee; Joshua L Deignan; Samuel P Strom; Sibel Kantarci; Xizhe Wang; Fabiola Quintero-Rivera; Eric Vilain; Wayne W Grody; Susan Perlman; Daniel H Geschwind; Stanley F Nelson
Journal:  JAMA Neurol       Date:  2014-10       Impact factor: 18.302

7.  Encoding of Ca2+ signals by differential expression of IP3 receptor subtypes.

Authors:  T Miyakawa; A Maeda; T Yamazawa; K Hirose; T Kurosaki; M Iino
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

8.  Synthetic partial agonists reveal key steps in IP3 receptor activation.

Authors:  Ana M Rossi; Andrew M Riley; Stephen C Tovey; Taufiq Rahman; Olivier Dellis; Emily J A Taylor; Valery G Veresov; Barry V L Potter; Colin W Taylor
Journal:  Nat Chem Biol       Date:  2009-08-09       Impact factor: 15.040

9.  Heterozygous deletion of ITPR1, but not SUMF1, in spinocerebellar ataxia type 16.

Authors:  A Iwaki; Y Kawano; S Miura; H Shibata; D Matsuse; W Li; H Furuya; Y Ohyagi; T Taniwaki; J Kira; Y Fukumaki
Journal:  J Med Genet       Date:  2007-10-11       Impact factor: 6.318

10.  Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humans.

Authors:  Joyce van de Leemput; Jayanth Chandran; Melanie A Knight; Lynne A Holtzclaw; Sonja Scholz; Mark R Cookson; Henry Houlden; Katrina Gwinn-Hardy; Hon-Chung Fung; Xian Lin; Dena Hernandez; Javier Simon-Sanchez; Nick W Wood; Paola Giunti; Ian Rafferty; John Hardy; Elsdon Storey; R J McKinlay Gardner; Susan M Forrest; Elizabeth M C Fisher; James T Russell; Huaibin Cai; Andrew B Singleton
Journal:  PLoS Genet       Date:  2007-05-16       Impact factor: 5.917

View more
  7 in total

Review 1.  Structure and Function of IP3 Receptors.

Authors:  David L Prole; Colin W Taylor
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-04-01       Impact factor: 10.005

2.  Inositol 1,4,5-trisphosphate Receptor Mutations associated with Human Disease.

Authors:  Lara E Terry; Kamil J Alzayady; Esraa Furati; David I Yule
Journal:  Messenger (Los Angel)       Date:  2018-06

Review 3.  Ion channel dysfunction in cerebellar ataxia.

Authors:  David D Bushart; Vikram G Shakkottai
Journal:  Neurosci Lett       Date:  2018-02-05       Impact factor: 3.046

4.  Aberrant IP3 receptor activities revealed by comprehensive analysis of pathological mutations causing spinocerebellar ataxia 29.

Authors:  Hideaki Ando; Matsumi Hirose; Katsuhiko Mikoshiba
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-14       Impact factor: 12.779

5.  Redox regulation of type-I inositol trisphosphate receptors in intact mammalian cells.

Authors:  Suresh K Joseph; Michael P Young; Kamil Alzayady; David I Yule; Mehboob Ali; David M Booth; György Hajnóczky
Journal:  J Biol Chem       Date:  2018-09-18       Impact factor: 5.157

Review 6.  Inositol 1,4,5-Trisphosphate Receptors in Human Disease: A Comprehensive Update.

Authors:  Jessica Gambardella; Angela Lombardi; Marco Bruno Morelli; John Ferrara; Gaetano Santulli
Journal:  J Clin Med       Date:  2020-04-12       Impact factor: 4.241

Review 7.  Roles for the Endoplasmic Reticulum in Regulation of Neuronal Calcium Homeostasis.

Authors:  Nicholas E Karagas; Kartik Venkatachalam
Journal:  Cells       Date:  2019-10-10       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.